CSIS WARRANT SERIES I vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? CSIS WARRANT SERIES I trades at Rp85 (market cap 4.6B, 4.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 74.8K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 36.4× CSIS WARRANT SERIES I's market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (74.8K versus 4.2K). Which is the better fit depends on your goals.
| CSIS-W | OBAT | |
|---|---|---|
Market Cap | 4.6B | 167.37B |
Volume | 4.2K | 74.8K |
Lot | 42 | 748 |
Turnover | 357.3K | 18.41M |
Average Price | 85.07 | 246.12 |
Value | 357.3K | 18.41M |
Indicative Equilibrium Price | — | 246 |
Indicative Equilibrium Volume | — | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.
Read more on CSIS-W →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →